Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
April-2025 Volume 31 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2025 Volume 31 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress

  • Authors:
    • Yan Su
    • Hack Sun Choi
    • Soon Kyu Kwon
    • Yunjon Han
    • Soon-Chang Cho
    • Jin Hyuk Shin
    • Yong-Suk Jang
    • Jong Hyun Choi
    • Jeong-Woo Seo
  • View Affiliations / Copyright

    Affiliations: Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, Jeollabuk 56212, Republic of Korea, Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea, Biocorp Co., Ltd., Goheung‑gun, Jeollanam 59551, Republic of Korea, Department of Bioactive Material Sciences, Jeonbuk National University, Jeonju, Jeollabuk 54896, Republic of Korea
    Copyright: © Su et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 86
    |
    Published online on: February 3, 2025
       https://doi.org/10.3892/mmr.2025.13451
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Asthma is a chronic allergic respiratory disease lacking effective therapies. The present study investigated the anti‑asthmatic properties of lipid mediators using an ovalbumin (OVA)‑induced allergic asthma model. Lipid mediators (LM; 17S‑monohydroxy docosahexaenoic acid, resolvin D5 and protectin DX at a ratio of 3:47:50) were derived from docosahexaenoic acid through soybean lipoxygenase. LM treatment significantly alleviated major features of allergic asthma, including inflammatory cell infiltration, with a particular reduction in eosinophils in bronchoalveolar lavage fluid, downregulation of Th2 cytokine expression, attenuation of airway remodeling, and oxidative stress, thereby closely resembling the normal condition. Additionally, a significant increase in the serum levels of interleukin‑6 [167.12±6.25 pg/ml; P<0.0001 vs. negative control (NC) group], tumor necrosis factor‑α (109.17±7.17 pg/ml; P<0.0001 vs. NC group) and IgE (90.24±5.98 ng/ml; P<0.0001 vs. NC group) was observed following OVA challenge; however, oral administration of LM resulted in a notable reduction in these levels to 99.45±6.12 pg/ml (P<0.001 vs. OVA group), 62.51±4.03 pg/ml (P<0.001 vs. OVA group) and 56.50±2.70 ng/ml (P<0.001 vs. OVA group), respectively. Furthermore, the heightened expression of Th2‑related cytokines induced by OVA was observed to be restored closely to normal conditions following LM treatment, as demonstrated for both gene and protein expression levels. Histological analysis demonstrated that LM mitigated inflammatory cell infiltration while reducing mucus secretion. Additionally, LM effectively ameliorated oxidative stress in OVA‑induced asthma, with a significant increase in the activity of superoxide dismutase (~185% vs. OVA group; P<0.001), elevated levels of glutathione (~74% higher than the OVA group; P<0.001) and reduced content of malondialdehyde (~40% lower than the OVA group; P<0.001) in lung tissues. Collectively, these findings suggested that LM effectively protected lung tissues from inflammation and oxidative stress, thereby representing a promising therapeutic option for the treatment of allergic asthma.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Pawankar R: Allergic diseases and asthma: A global public health concern and a call to action. World Allergy Organ J. 7:122014. View Article : Google Scholar : PubMed/NCBI

2 

Agache I, Eguiluz-Gracia I, Cojanu C, Laculiceanu A, Del Giacco S, Zemelka-Wiacek M, Kosowska A, Akdis CA and Jutel M: Advances and highlights in asthma in 2021. Allergy. 76:3390–3407. 2021. View Article : Google Scholar : PubMed/NCBI

3 

Lambrecht BN and Hammad H: The immunology of asthma. Nat Immunol. 16:45–56. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Possa SS, Leick EA, Prado CM, Martins MA and Tibério IFLC: Eosinophilic inflammation in allergic asthma. Front Pharmacol. 4:462013. View Article : Google Scholar : PubMed/NCBI

5 

Hammad H and Lambrecht BN: The basic immunology of asthma. Cell. 184:1469–1485. 2021. View Article : Google Scholar : PubMed/NCBI

6 

Stokes JR and Casale TB: Characterization of asthma endotypes: Implications for therapy. Ann Allergy Asthma Immunol. 117:121–125. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Abdelaziz MH, Abdelwahab SF, Wan J, Cai W, Huixuan W, Jianjun C, Kumar KD, Vasudevan A, Sadek A, Su Z, et al: Alternatively activated macrophages; a double-edged sword in allergic asthma. J Transl Med. 18:582020. View Article : Google Scholar : PubMed/NCBI

8 

Ma Y, Ge A, Zhu W, Liu YN, Ji NF, Zha WJ, Zhang JX, Zeng XN and Huang M: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling. Oxid Med Cell Longev. 2016:58436722016. View Article : Google Scholar : PubMed/NCBI

9 

Saeedavi M, Goudarzi M, Mehrzadi S, Basir Z, Hasanvand A and Hosseinzadeh A: Sinapic acid ameliorates airway inflammation in murine ovalbumin-induced allergic asthma by reducing Th2 cytokine production. Life Sci. 307:1208582022. View Article : Google Scholar : PubMed/NCBI

10 

Ezz-Eldin YM, Aboseif AA and Khalaf MM: Potential anti-inflammatory and immunomodulatory effects of carvacrol against ovalbumin-induced asthma in rats. Life Sci. 242:1172222020. View Article : Google Scholar : PubMed/NCBI

11 

Zafar MS, Shahid K, Gobe GC, Yasmin R, Naseem N and Shahzad M: Suppression of cytokine storm and associated inflammatory mediators by salicylaldehyde derivative of pregabalin: An innovative perspective for alleviating airway inflammation and lung remodeling. J King Saud Univ Sci. 34:1018772022. View Article : Google Scholar

12 

Sahiner UM, Birben E, Erzurum S, Sackesen C and Kalayci O: Oxidative stress in asthma. World Allergy Organ J. 4:151–158. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Bowler RP and Crapo JD: Oxidative stress in airways: Is there a role for extracellular superoxide dismutase? Am J Respir Crit Care Med. 166:S38–S43. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Michaeloudes C, Abubakar-Waziri H, Lakhdar R, Raby K, Dixey P, Adcock IM, Mumby S, Bhavsar PK and Chung KF: Molecular mechanisms of oxidative stress in asthma. Mol Aspects Med. 85:1010262022. View Article : Google Scholar : PubMed/NCBI

15 

Lee KS, Lee HK, Hayflick JS, Lee YC and Puri KD: Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J. 20:455–465. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Ganesh Yerra V, Negi G, Sharma SS and Kumar A: Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy. Redox Biol. 1:394–397. 2013. View Article : Google Scholar : PubMed/NCBI

17 

El-Hashim AZ, Renno WM, Abduo HT, Jaffal SM, Akhtar S and Benter IF: Effect of inhibition of the ubiquitin-proteasome-system and IκB kinase on airway inflammation and hyperresponsiveness in a murine model of asthma. Int J Immunopathol Pharmacol. 24:33–42. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Li J, Xun P, Zamora D, Sood A, Liu K, Daviglus M, Iribarren C, Jacobs D Jr, Shikany JM and He K: Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: The CARDIA study. Am J Clin Nutr. 97:173–178. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Wendell SG, Baffi C and Holguin F: Fatty acids, inflammation, and asthma. J Allergy Clin Immunol. 133:1255–1264. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Kitz R, Rose MA, Schubert R, Beermann C, Kaufmann A, Böhles HJ, Schulze J and Zielen S: Omega-3 polyunsaturated fatty acids and bronchial inflammation in grass pollen allergy after allergen challenge. Respir Med. 104:1793–1798. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Siddiquee A, Patel M, Rajalingam S, Narke D, Kurade M and Ponnoth DS: Effect of omega-3 fatty acid supplementation on resolvin (RvE1)-mediated suppression of inflammation in a mouse model of asthma. Immunopharmacol Immunotoxicol. 41:250–257. 2019. View Article : Google Scholar : PubMed/NCBI

22 

Miyata J and Arita M: Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int. 64:27–34. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Duvall MG and Levy BD: DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol. 785:144–155. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Koltsida O, Karamnov S, Pyrillou K, Vickery T, Chairakaki AD, Tamvakopoulos C, Sideras P, Serhan CN and Andreakos E: Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol Med. 5:762–775. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Levy BD: Resolvin D1 and Resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways. Front Immunol. 3:3902012. View Article : Google Scholar : PubMed/NCBI

26 

Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, Pfeffer MA, Priluck R, Serhan CN and Levy BD: Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol. 189:1983–1991. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K and Mori M: Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun. 367:509–515. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Su Y, Han Y, Choi HS, Lee GY, Cho HW, Choi H, Jang YS, Choi JH and Seo JW: Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice. Int Immunopharmacol. 124:1109002023. View Article : Google Scholar : PubMed/NCBI

29 

Zhou R, Shi X, Gao Y, Cai N, Jiang Z and Xu X: Anti-inflammatory activity of guluronate oligosaccharides obtained by oxidative degradation from alginate in lipopolysaccharide-activated murine macrophage RAW 264.7 cells. J Agric Food Chem. 63:160–168. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Sun N, Teng A, Zhao Y, Liu H, Tu J, Jia Q and Wang Q: Immunological and anticancer activities of seleno-ovalbumin (Se-OVA) on H22-bearing mice. Int J Biol Macromol. 163:657–665. 2020. View Article : Google Scholar : PubMed/NCBI

31 

Su Y, Han Y, Choi HS, Lee GY, Cho HW, Choi H, Choi JH, Jang YS and Seo JW: Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase attenuate RANKL-induced osteoclast differentiation and rheumatoid arthritis. Biomed Pharmacother. 171:1161532024. View Article : Google Scholar : PubMed/NCBI

32 

Wu D, Li S, Liu X, Xu J, Jiang A, Zhang Y, Liu Z, Wang J, Zhou E, Wei Z, et al: Alpinetin prevents inflammatory responses in OVA-induced allergic asthma through modulating PI3K/AKT/NF-κB and HO-1 signaling pathways in mice. Int Immunopharmacol. 89:1070732020. View Article : Google Scholar : PubMed/NCBI

33 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Lambrecht BN, Hammad H and Fahy JV: The cytokines of asthma. Immunity. 50:975–991. 2019. View Article : Google Scholar : PubMed/NCBI

35 

Karadogan B, Beyaz S, Gelincik A, Buyukozturk S and Arda N: Evaluation of oxidative stress biomarkers and antioxidant parameters in allergic asthma patients with different level of asthma control. J Asthma. 59:663–672. 2022. View Article : Google Scholar : PubMed/NCBI

36 

Cho YS and Moon H-B: The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol Res. 2:183–187. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Huang WC, Fang LW and Liou CJ: Phloretin attenuates allergic airway inflammation and oxidative stress in asthmatic mice. Front Immunol. 8:1342017. View Article : Google Scholar : PubMed/NCBI

38 

Schubert R, Kitz R, Beermann C, Rose MA, Lieb A, Sommerer PC, Moskovits J, Alberternst H, Böhles HJ, Schulze J and Zielen S: Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int Arch Allergy Immunol. 148:321–329. 2009. View Article : Google Scholar : PubMed/NCBI

39 

Mickleborough TD, Lindley MR, Ionescu AA and Fly AD: Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 129:39–49. 2006. View Article : Google Scholar : PubMed/NCBI

40 

Yokoyama A, Hamazaki T, Ohshita A, Kohno N, Sakai K, Zhao GD, Katayama H and Hiwada K: Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma. Int Arch Allergy Immunol. 123:327–332. 2000. View Article : Google Scholar : PubMed/NCBI

41 

Morin C, Fortin S, Cantin AM and Rousseau É: MAG-EPA resolves lung inflammation in an allergic model of asthma. Clin Exp Allergy. 43:1071–1082. 2013. View Article : Google Scholar : PubMed/NCBI

42 

Jiang T, Li P, Zhao J, Dai L, Sun D, Liu M, An L, Jia L, Jing X, Wang H, et al: Long-chain polyunsaturated fatty acids improve airway pathological features and gut microbial imbalances in BALB/c mice with ovalbumin-induced asthma. J Funct Foods. 81:1044652021. View Article : Google Scholar

43 

Yin H, Liu W, Goleniewska K, Porter NA, Morrow JD and Peebles RS Jr: Dietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation. Free Radic Biol Med. 47:622–628. 2009. View Article : Google Scholar : PubMed/NCBI

44 

Schuster GU, Bratt JM, Jiang X, Pedersen TL, Grapov D, Adkins Y, Kelley DS, Newman JW, Kenyon NJ and Stephensen CB: Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice. Am J Respir Cell Mol Biol. 50:626–636. 2014. View Article : Google Scholar : PubMed/NCBI

45 

Miyata J, Fukunaga K, Iwamoto R, Isobe Y, Niimi K, Takamiya R, Takihara T, Tomomatsu K, Suzuki Y, Oguma T, et al: Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J Allergy Clin Immunol. 131:353–360.e2-e2. 2013. View Article : Google Scholar : PubMed/NCBI

46 

Zambalde ÉP, Teixeira MM, Favarin DC, de Oliveira JR, Magalhães ML, Cunha MM, Silva WC Jr, Okuma CH, Rodrigues V Jr, Levy BD and Rogerio AP: The anti-inflammatory and pro-resolution effects of aspirin-triggered RvD1 (AT-RvD1) on peripheral blood mononuclear cells from patients with severe asthma. Int Immunopharmacol. 35:142–148. 2016. View Article : Google Scholar : PubMed/NCBI

47 

Peh HY, Bruggemann TR, Ho WE, Cheng C, Tan WD, Wong WF and Levy BD: Resolvin D2 promotes the resolution of allergen-induced lung inflammation. J Immunol. 204 (1 Suppl):S147.192020. View Article : Google Scholar

48 

Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, O'Byrne PM and Inman MD: Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med. 169:860–867. 2004. View Article : Google Scholar : PubMed/NCBI

49 

Platts-Mills TAE, Schuyler AJ, Erwin EA, Commins SP and Woodfolk JA: IgE in the diagnosis and treatment of allergic disease. J Allergy Clin Immunol. 137:1662–1670. 2016. View Article : Google Scholar : PubMed/NCBI

50 

Ingram JL and Kraft M: IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies. J Allergy Clin Immunol. 130:829–844. 2012. View Article : Google Scholar : PubMed/NCBI

51 

Alasandagutti ML, Ansari MSS, Sagurthi SR, Valluri V and Gaddam S: Role of IL-13 genetic variants in signalling of asthma. Inflammation. 40:566–577. 2017. View Article : Google Scholar : PubMed/NCBI

52 

Curran DR and Cohn L: Advances in mucous cell metaplasia: A plug for mucus as a therapeutic focus in chronic airway disease. Am J Respir Cell Mol Biol. 42:268–275. 2010. View Article : Google Scholar : PubMed/NCBI

53 

Lai H and Rogers DF: New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: Targeting intracellular signaling pathways. J Aerosol Med Pulm Drug Deliv. 23:219–231. 2010. View Article : Google Scholar : PubMed/NCBI

54 

Adner M, Rose AC, Zhang Y, Swärd K, Benson M, Uddman R, Shankley NP and Cardell LO: An assay to evaluate the long-term effects of inflammatory mediators on murine airway smooth muscle: Evidence that TNFalpha up-regulates 5-HT(2A)-mediated contraction contraction. Br J Pharmacol. 137:971–982. 2002. View Article : Google Scholar : PubMed/NCBI

55 

Dienz O and Rincon M: The effects of IL-6 on CD4 T cell responses. Clin Immunol. 130:27–33. 2009. View Article : Google Scholar : PubMed/NCBI

56 

Henderson WR Jr, Chi EY, Teo JL, Nguyen C and Kahn M: A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol. 169:5294–5299. 2002. View Article : Google Scholar : PubMed/NCBI

57 

Poynter ME: Airway epithelial regulation of allergic sensitization in asthma. Pulm Pharmacol Ther. 25:438–446. 2012. View Article : Google Scholar : PubMed/NCBI

58 

Ma B, Athari SS, Mehrabi Nasab E and Zhao L: PI3K/AKT/mTOR and TLR4/MyD88/NF-κB signaling inhibitors attenuate pathological mechanisms of allergic asthma. Inflammation. 44:1895–1907. 2021. View Article : Google Scholar : PubMed/NCBI

59 

Bao Z, Zhang P, Yao Y, Lu G, Tong Z, Yan B, Tu L, Yang G and Zhou J: Deguelin attenuates allergic airway inflammation via inhibition of NF-κb pathway in mice. Int J Biol Sci. 13:492–504. 2017. View Article : Google Scholar : PubMed/NCBI

60 

Das J, Chen CH, Yang L, Cohn L, Ray P and Ray A: A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol. 2:45–50. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Su Y, Choi HS, Kwon SK, Han Y, Cho S, Shin JH, Jang Y, Choi JH and Seo J: Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress. Mol Med Rep 31: 86, 2025.
APA
Su, Y., Choi, H.S., Kwon, S.K., Han, Y., Cho, S., Shin, J.H. ... Seo, J. (2025). Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress. Molecular Medicine Reports, 31, 86. https://doi.org/10.3892/mmr.2025.13451
MLA
Su, Y., Choi, H. S., Kwon, S. K., Han, Y., Cho, S., Shin, J. H., Jang, Y., Choi, J. H., Seo, J."Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress". Molecular Medicine Reports 31.4 (2025): 86.
Chicago
Su, Y., Choi, H. S., Kwon, S. K., Han, Y., Cho, S., Shin, J. H., Jang, Y., Choi, J. H., Seo, J."Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress". Molecular Medicine Reports 31, no. 4 (2025): 86. https://doi.org/10.3892/mmr.2025.13451
Copy and paste a formatted citation
x
Spandidos Publications style
Su Y, Choi HS, Kwon SK, Han Y, Cho S, Shin JH, Jang Y, Choi JH and Seo J: Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress. Mol Med Rep 31: 86, 2025.
APA
Su, Y., Choi, H.S., Kwon, S.K., Han, Y., Cho, S., Shin, J.H. ... Seo, J. (2025). Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress. Molecular Medicine Reports, 31, 86. https://doi.org/10.3892/mmr.2025.13451
MLA
Su, Y., Choi, H. S., Kwon, S. K., Han, Y., Cho, S., Shin, J. H., Jang, Y., Choi, J. H., Seo, J."Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress". Molecular Medicine Reports 31.4 (2025): 86.
Chicago
Su, Y., Choi, H. S., Kwon, S. K., Han, Y., Cho, S., Shin, J. H., Jang, Y., Choi, J. H., Seo, J."Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress". Molecular Medicine Reports 31, no. 4 (2025): 86. https://doi.org/10.3892/mmr.2025.13451
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team